Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

HOOKIPA Pharma Inc. - Common Stock (NQ:HOOK)

1.500 -0.120 (-7.41%)
Streaming Delayed Price Updated: 12:25 PM EDT, May 23, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about HOOKIPA Pharma Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >
HOOKIPA Pharma (NASDAQ: HOOK) Enters into Collaboration Deal with Roche to Develop HB-700 For KRAS-Mutated Cancers
HOOKIPA Pharma, Inc. (NASDAQ: HOOK) is engaged as a clinical-stage biopharmaceutical company, which is focused on the research and development 
Via Spotlight Growth
Why Is Indonesia Energy (INDO) Stock Up Today?
Indonesia Energy (INDO) stock is climbing higher on Thursday after the company announced the discovery of oil in one of its new wells. 
Via InvestorPlace
Why Is Hookipa (HOOK) Stock Up 26% Today?
Hookipa (HOOK) stock is rocketing higher on Thursday after reaching a strategic collaboration and license agreement with Roche (RHHBF). 
Via InvestorPlace
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers HOOKIPA Pharma (NASDAQ:HOOK) stock increased by 45.5% to $1.76 during Thursday's pre-market session. The market value of their outstanding shares is at $96.2 million. 
Via Benzinga
HOOKIPA announces strategic collaboration and license agreement with Roche to develop novel arenaviral immunotherapy for KRAS-mutated cancers
From HOOKIPA Pharma Inc.
Via GlobeNewswire
Recap: HOOKIPA Pharma Q2 Earnings
  HOOKIPA Pharma (NASDAQ:HOOK) reported its Q2 earnings results on Thursday, August 11, 2022 at 07:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
  
Via Benzinga
HOOKIPA Gets FDA Nod For Initial-Stage Prostate Cancer Study
The U.S. Food and Drug Administration (FDA) has accepted HOOKIPA Pharma’s (NASDAQ: HOOK) Investigational New Drug (IND) application for HB-300, a novel arenaviral immunotherapy for the treatment of... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
HOOKIPA Pharma's Return On Capital Employed Insights
According to data from Benzinga Pro, during Q1, HOOKIPA Pharma's (NASDAQ:HOOK) reported sales totaled $1.45 million. Despite a 15.38% increase in earnings, the company posted a loss of $17.97 million. 
Via Benzinga
Recap: HOOKIPA Pharma Q1 Earnings
HOOKIPA Pharma (NASDAQ:HOOK) reported its Q1 earnings results on Monday, May 16, 2022 at 07:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Earnings Scheduled For May 16, 2022
Companies Reporting Before The Bell • AcelRx Pharmaceuticals (NASDAQ:ACRX) is estimated to report quarterly loss at $0.06 per share on revenue of $550.00 thousand. 
Via Benzinga
Hookipa Shares Jump On New Preclinical Data On Cancer Immunotherapies
HOOKIPA Pharma Inc (NASDAQ: HOOK) has  
Via Benzinga
HOOKIPA Pharma: Q4 Earnings Insights
HOOKIPA Pharma (NASDAQ:HOOK) reported its Q4 earnings results on Thursday, March 24, 2022 at 07:00 AM. Here's what investors need to know about the... 
Via Benzinga
The Daily Biotech Pulse: Aeglea Stock Jumps On Inherited Metabolic Disease Data, Partial Hold Lifted On Gilead's 2 Blood Trials, Early Data From Novartis' KRAS Inhibitor And More
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
The Week Ahead In Biotech (April 10-April 16): Regeneron FDA Decision, Cancer Conference Presentations And More
Biotech stocks managed to carve out modest gains for the week ending April 8, defying the broader market weakness. The defensive nature of the stocks make them appealing in times of risk aversion. 
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Gainers Cognition Therapeutics (NASDAQ:CGTX) shares increased by 26.2% to $3.28 during Monday's regular session. Trading volume for Cognition Therapeutics's stock... 
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
  
Via Benzinga
HOOKIPA Pharma's Return On Capital Employed Overview
Benzinga Pro data, HOOKIPA Pharma (NASDAQ:HOOK) reported Q4 sales of $3.90 million. Earnings fell to a loss of $21.23 million, resulting in a 5.96% decrease from last quarter.... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers BiondVax Pharmaceuticals (NASDAQ:BVXV) shares moved upwards by 55.5% to $2.13 during Thursday's pre-market session. The market value of their outstanding... 
Via Benzinga
The Daily Biotech Pulse: Novartis Prostate Cancer Drug Lands FDA Approval, Ligand Announces SPAC Deal To Spin Off Antibody Business, Lilly's Lung Cancer Therapy Hit With CRL
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
Earnings Scheduled For March 24, 2022
Companies Reporting Before The Bell • iHuman (NYSE:IH) is likely to report earnings for its fourth quarter. • Pioneer Muni High Inc (NYSE:MAV) is expected to... 
Via Benzinga
HOOKIPA Pharma Earnings Preview
HOOKIPA Pharma (NASDAQ:HOOK) is set to give its latest quarterly earnings report on Thursday, 2022-03-24. Here's what investors need to know before the announcement. Analysts... 
Via Benzinga
The Week Ahead In Biotech (March 20-26): Focus On Zogenix FDA Decision, Dermatology Conference Presentations & Earnings
Biotech stocks rebounded along with the broader market in the week ending March 18, as risk appetite returned. Multiple conference presentations, clinical readouts and earnings news dictated sentiment... 
Via Benzinga
How To Attend HOOKIPA Pharma Q4 2021 Earnings Conference Call
HOOKIPA Pharma (NASDAQ:HOOK) will host a conference call at 08:30 AM ET on March 24, 2022, to discuss Q4 2021 earnings results. How to Attend HOOKIPA Pharma (HOOK) Conference Call... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers Trevi Therapeutics (NASDAQ:TRVI) shares rose 46.6% to $1.28 during Wednesday's regular session. As of 12:30 EST, Trevi Therapeutics's stock is trading at a... 
Via Benzinga
41 Stocks Moving In Wednesday's Mid-Day Session
Gainers ECMOHO Limited (NASDAQ: MOHO) jumped 67% to $0.3890 after jumping 10% on Tuesday. Nordstrom, Inc. (NYSE: JWN) shares jumped 38.7% to $27.11 after the company reported... 
Via Benzinga
68 Biggest Movers From Yesterday
Gainers ECMOHO Limited (NASDAQ: MOHO) climbed 56.7% to close at $0.3650 on Wednesday after jumping 10% on Tuesday. Imperial Petroleum Inc. (NASDAQ: IMPP) shares jumped 39.2% to... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers IsoPlexis (NASDAQ:ISO) shares moved upwards by 22.8% to $5.5 during Wednesday's pre-market session. The company's market cap stands at $214.2 million. The... 
Via Benzinga
The Daily Biotech Pulse: Karyopharm Flags Delay In Selinexor Label Expansion, Finch, Celyad Hit With Clinical Holds, Adagene Strikes R&D Collaboration With Sanofi
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Karyopharm Says FDA Mandates Additional Study For Expanding Selinexor Label... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.